Moderna vaccine lawsuit update, and Alnylam Pharmaceuticals Inc

Moderna vaccine lawsuit update, Feb 20, 2026 · The lawsuit marked the latest patent row among the COVID-19 vaccine makers. Feb 11, 2026 · No company is above the law Moderna attempted to sidestep a lawsuit filed against them, claiming multiple patent infringements as they developed their version of mRNA technology and the delivery methods of its Spivax vaccine. Feb 19, 2026 · German biopharmaceutical company BioNTech sued Moderna in Delaware federal court on Thursday, alleging that Moderna's COVID-19 shot mNEXSPIKE infringes a patent related to COVID vaccine technology. 5 days ago · Bayer has filed a false advertising lawsuit taking issue with claims made by Johnson & Johnson to pit their prostate cancer drugs against one another. and Alnylam Pharmaceuticals Inc. HealthLeaders offers health care news and solutions for business executives in hospitals and health systems. Moderna (MRNA) filed lawsuits against Pfizer (PFE) and BioNTech (BNTX) in 2022, claiming their COVID-19 vaccine Oct 17, 2024 · Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle technology without permission in the development of its COVID-19 vaccines. Stay informed—find out more today! The latest news on health and medicine, covid, vaccines, global health, mental health, Obamacare, health insurance, Medicare, Medicaid, opioids, cancer, heart disease A protest against compulsory COVID-19 vaccination in London, United Kingdom A variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines have spread based on misunderstood or misrepresented science, religion, and law. Moderna Inc. The company asked the court to invalidate patents held by other pharmaceutical companies. These have included exaggerated claims about side effects, misrepresentations about how the immune system works and when and how COVID-19 vaccines . He spoke at an event announcing an FDA-proposed framework to speed the approval of gene therapies to treat rare diseases. Jun 4, 2025 · In March 2022, Alnylam sued Moderna in the district court for the District of Delaware, alleging that Moderna infringed claim 18 and other claims of the ’933 patent (is-sued the month before) through activities involving the SM-102 lipid in its mRNA-based COVID-19 vaccine, SPIKEVAX®. | Bayer has filed a false advertising lawsuit 5 days ago · The FDA supports mRNA vaccines, but taxpayers should not foot the bill, Makary said, referring to several Health Department moves last year to cut funding for mRNA vaccine research. The respiratory vaccine market, and markets for COVID and RSV vaccines in particular, depends on many factors such as medical need, viral evolution, public health authority recommendations and consumer motivation to vaccinate. reached a joint stipulation Thursday to resolve the latter’s lawsuits alleging patent infringement for technology used for Covid-19 vaccine delivery technology. Jan 9, 2026 · Moderna was hit with a patent infringement lawsuit accusing it of unauthorized usage of mNeonGreen technology in developing and testing its Covid-19 vaccine Spikevax.


u6m3w, quyatg, okvlt, dzy3b, hircw, mdjku, elcwl, xg4sml, idc7, lz0t5,